Optical platform for functional longitudinal imaging of metabolite uptake in vivo
用于体内代谢物摄取功能纵向成像的光学平台
基本信息
- 批准号:10585764
- 负责人:
- 金额:$ 34.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-15 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAddressAffinityAmino AcidsAnimal Cancer ModelAnimal Disease ModelsAnimal ModelAnimalsAzidesBehaviorBiologicalBiological AssayBreast Cancer ModelCRISPR/Cas technologyCategoriesCell Culture TechniquesCell modelCellsChemistryClinicalDependenceDevelopmentDiabetes MellitusDisease ProgressionEnzymesEvaluationFatty AcidsFirefliesGenerationsGlucoseGlutamineGoalsHumanHuman PathologyImageImaging DeviceImaging TechniquesIn VitroInterventionIntraperitoneal InjectionsInvestigationIsotopesKineticsLigationLightLuc GeneLuciferasesMagnetic Resonance ImagingMalignant NeoplasmsMeasurementMetabolicMetabolic DiseasesMetabolismMethodsModificationMolecular ProbesMonitorMusNatureNeurodegenerative DisordersNormal CellNucleosidesNucleotidesNutrientOleic AcidsOncologyOpticsOralPathologicPhysiologicalPlayPositron-Emission TomographyProcessProductionProliferatingPublishingRadioactiveReactionReagentReportingRoleRouteSafetySignal TransductionSpecificityStructureSynthesis ChemistrySystemTechniquesTechnologyTestingTherapeuticTimeTissuesToxic effectTransgenic MiceTransgenic OrganismsTryptophanTubeValidationWorkabsorptionanalytical methodanalytical toolbiological systemsbioluminescence imagingcancer cellcancer therapychemotherapyclinical applicationcostdesigndrug discoveryeffective therapyexperimental studyglucose uptakehuman modelimaging modalityimaging platformimprovedin vitro Modelin vivoinhibitorinterestintravenous injectionluciferinmetabolic abnormality assessmentmolecular imagingnew technologynon-invasive imagingnonalcoholic steatohepatitisnovelnuclear imagingoptical imagingserial imagingsimulationsingle photon emission computed tomographysmall hairpin RNAsuccesstherapeutic targettooltumortumor growthtumor metabolismtumor microenvironmenttumorigenesisuptake
项目摘要
PROJECT SUMMARY
Cancer cells undergo metabolic reprogramming in order to meet elevated energy requirements to fuel
proliferation, thus resulting in their differential utilization of many essential metabolites compared to normal cells.
Recent advancements in the field of cancer metabolic reprogramming demonstrated significant increase in
efficiency of standard cancer treatments when combined with cancer metabolic inhibitors. However, tumor
metabolic reprogramming remains poorly understood for the majority of cancers. Moreover, many recent reports
revealed evidence that the metabolism of cancer cells in vitro can differ significantly from that of in vivo because
in vitro models lack complexity of the tumor microenvironment. However, the progress of studying tumor
metabolism in vivo is significantly hampered by the lack of efficient tools that allow real-time noninvasive imaging
and quantification of metabolite absorption in animal models of cancer which closely reflect human pathologies.
Current strategies have significant limitations and mostly rely on MRI, nuclear imaging techniques such as
PET/SPECT, and endpoint ex vivo quantification of metabolite absorption (ex. MS). Here, we propose to develop
a novel optical imaging platform that has several important advantages over the existing methods, and allows
noninvasive evaluation of the uptake of several essential metabolites using highly sensitive and quantifiable
bioluminescent imaging. The method is independent of radioactive and/or short-lived isotopes, less costly, and
allows longitudinal monitoring of metabolite absorption during disease progression (e.g., cancer development or
clinical intervention such as chemotherapy). While the first application of this approach has been already
successfully validated by us using glucose as an example (Maric et.al., Nat Methods, 2019), we propose to
expand this technology to develop novel probes to study uptake of several amino acids, fatty acids, and
nucleosides that all play central role in cancer metabolic reprogramming. We will perform thorough validation of
this platform in cells, healthy transgenic mice and murine animal cancer models to assure that the reagents fulfill
the requirements for physiological behavior, stability, safety, and robust signal generation both in vitro and in
vivo. In addition, we will optimize in vivo delivery routes, vehicles, and concentrations to achieve high
signal/background ratios. In summary, the overall goal of this study is to generate a novel optical imaging platform
that would become a universal analytical tool for monitoring nutrient uptake in live cells and animal models of
disease. While we plan to apply this platform to unravel tumor metabolic reprogramming, the same method could
be adapted for studies of several other important human pathologies, in which changes in metabolism are known
to play a significant role, such as diabetes, neurodegenerative diseases, nonalcoholic steatohepatitis (NASH),
and many others. Therefore, this novel technology is expected to have a strong, enabling, and long-lasting impact
on many physiological and pathological investigations in the field of metabolism and will become a valuable tool
for drug discovery, applicable to oncology and other metabolic disorders.
项目总结
癌细胞进行新陈代谢重新编程,以满足更高的能量需求以提供燃料
因此,与正常细胞相比,它们对许多必需代谢物的利用存在差异。
癌症代谢再编程领域的最新进展显示,
当与癌症代谢抑制剂联合使用时,标准癌症治疗的有效性。然而,肿瘤
对于大多数癌症来说,代谢重编程仍然知之甚少。而且,最近的许多报道,
发现的证据表明,癌细胞在体外的代谢与体内的代谢可以有很大的不同,因为
体外模型缺乏肿瘤微环境的复杂性。然而,肿瘤的研究进展
由于缺乏能够进行实时非侵入性成像的有效工具,体内的新陈代谢严重受阻
以及在癌症动物模型中对代谢物吸收的量化,这与人类的病理密切相关。
目前的策略有很大的局限性,主要依赖于磁共振成像、核成像技术,如
PET/SPECT和体外代谢产物吸收终点定量(例如Ms)。在这里,我们建议开发
一种新型光学成像平台,与现有方法相比具有几个重要的优点,并允许
用高灵敏度和可定量的方法对几种主要代谢物的摄取进行无创评估
生物发光成像。该方法不受放射性和/或短寿命同位素的影响,成本较低,
允许在疾病进展期间(例如,癌症发展或
临床干预,如化疗)。虽然这种方法的第一次应用已经
我们以葡萄糖为例成功地验证了(Maric等人,NAT方法,2019),我们建议
扩展这项技术以开发新的探针来研究几种氨基酸、脂肪酸和
核苷都在癌症代谢重新编程中起着核心作用。我们将进行彻底的验证
该平台在细胞、健康转基因小鼠和小鼠癌症动物模型中确保试剂满足
在体外和体外对生理行为、稳定性、安全性和强健信号产生的要求
活着。此外,我们还将优化体内给药路线、车辆和浓度,以实现高
信号/背景比。总之,本研究的总体目标是生成一种新型的光学成像平台
这将成为监测活细胞和动物模型中营养摄取的通用分析工具
疾病。虽然我们计划应用这个平台来解开肿瘤代谢重新编程,但同样的方法可以
适用于其他几种重要的人类病理研究,在这些研究中,代谢的变化是已知的
发挥重要作用,如糖尿病、神经退行性疾病、非酒精性脂肪性肝炎(NASH)、
还有其他许多人。因此,这项新技术有望产生强大的、使能的和持久的影响
关于新陈代谢领域的许多生理和病理研究,并将成为一个有价值的工具
用于药物发现,适用于肿瘤学和其他代谢紊乱。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elena Goun其他文献
Elena Goun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elena Goun', 18)}}的其他基金
A bioluminescent-based imaging probe for noninvasive longitudinal monitoring of CoQ10 uptake in vivo
基于生物发光的成像探针,用于体内 CoQ10 摄取的无创纵向监测
- 批准号:
10829717 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.2万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.2万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.2万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.2万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.2万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.2万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.2万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.2万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.2万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.2万 - 项目类别:
Research Grant